2 recruiting, 1 completed. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Recruiting 2, Completed 1 |
Follow Reflux Esophagitis (RE): new trials by email Literature Review of Reflux Esophagitis (RE) trials Research Report on Reflux Esophagitis (RE)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Trial of Anaprazole for Treating Reflux Esophagitis. Anaprazole + Rabeprazole placebo, Rabeprazole + Anaprazole placebo - Reflux Esophagitis (RE) | Phase 3 | Recruiting | Xuanzhu Biopharmaceutical Co., Ltd. | 500 | 2025-07-30 | 2025-09-29 |
| A Phase III Clinical Trial for Efficacy and Safety Evaluation of JP-1366 Tablets on Reflux Esophagitis JP-1366 simulation tablets, Esomeprazole Magnesium (Nexium) simulation tablets - Reflux Esophagitis (RE) | Phase 3 | Recruiting | Livzon Pharmaceutical Group Inc. | 356 | 2024-12-05 | 2025-02-27 |
| A Phase I/III Study of D961H 10 mg and 20 mg in Japanese Paediatric Patients With Gastrointestinal Acid Related Diseases D961H sachet 10 mg, D961H capsule 10mg, D961H capsule 20 mg - Gastric Ulcer (GU), Duodenal Ulcer (DU) | Phase 3 | Completed | AstraZeneca | 55 | 2014-06-01 | 2017-01-19 |
Esophagitis, Peptic (3) · Duodenal Ulcer (1) · Stomach Ulcer (1) · Zollinger-Ellison Syndrome (1)
Digestive System Diseases (3) · Duodenal Diseases (3) · Esophageal Diseases (3) · Esophagitis (3) · Gastroenteritis (3) · Gastrointestinal Diseases (3) · Intestinal Diseases (3) · Peptic Ulcer (3) · Stomach Diseases (3) · Digestive System Neoplasms (1) · Gastrointestinal Neoplasms (1) · Neoplasms (1) · Paraneoplastic Endocrine Syndromes (1) · Paraneoplastic Syndromes (1)
Esomeprazole (1) · Rabeprazole (1)
AstraZeneca (1) · Livzon Pharmaceutical Group Inc. (1) · Xuanzhu Biopharmaceutical Co., Ltd. (1)
China (2) · Japan (1)